Which Little Miss are you? 👩 If you want lifted eyelids, too, ask your healthcare provider about Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1%, to treat your acquired ptosis. Learn more at the link in bio. IMPORTANT SAFETY INFORMATION (Last Updated 6/17/2021) ​ UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat acquired blepharoptosis (low-lying eyelids) in adults.​ Warnings and precautions​ Low-lying eyelids may be related to conditions such as stroke and/or brain aneurysm, Horner syndrome, myasthenia gravis, loss of the ability to move eye muscles, eye infection and eye tumors. Your doctor should evaluate you for these conditions.​ Ask your doctor if you have any of the following conditions or if any of the following symptoms, which UPNEEQ may increase, get worse:​ -Heart disease, uncontrolled high or low blood pressure, or if you feel faint at rest or when quickly standing up;​ -Reduced blood flow to the brain or heart, or eye or mouth dryness due to an immune system disorder (Sjögren’s syndrome); ​ Increase in eye pressure due to fluid buildup due to untreated narrow-angle glaucoma.​ Do not let the tip of the UPNEEQ vial touch your eye or any other surface. This can help prevent eye injury or contamination. Each UPNEEQ vial is for one-time use. Discard after use.​ Common side effects​ The most common side effects with UPNEEQ (1-5% of patients) were eye inflammation, eye redness, dry eye, blurred vision, eye pain at time of use, eye irritation, and headache.​ Tell your doctor​ -Your full medical history.​ -If you currently take an alpha-adrenergic antagonist medication to treat heart disease or an enlarged prostate, beta-blockers, or other medications to treat hypertension or an abnormal heartbeat.​ -If you use a certain class of antidepressant medication (monoamine oxidase inhibitors), as it may affect the way your body absorbs the medication.​ ©2022 RVL Pharmaceuticals, Inc. All rights reserved.​​ Upneeq® is a registered trademark of RVL Pharmaceuticals, Inc.